NO20015488L - 14<beta>-H-steroler, farmasöytiske preparater som omfatter dem, og anvendelse av disse derivatene til fremstilling avmeioseregulerende medikamenter - Google Patents

14<beta>-H-steroler, farmasöytiske preparater som omfatter dem, og anvendelse av disse derivatene til fremstilling avmeioseregulerende medikamenter

Info

Publication number
NO20015488L
NO20015488L NO20015488A NO20015488A NO20015488L NO 20015488 L NO20015488 L NO 20015488L NO 20015488 A NO20015488 A NO 20015488A NO 20015488 A NO20015488 A NO 20015488A NO 20015488 L NO20015488 L NO 20015488L
Authority
NO
Norway
Prior art keywords
sterols
preparation
pharmaceutical compositions
bio
beta
Prior art date
Application number
NO20015488A
Other languages
English (en)
Other versions
NO20015488D0 (no
Inventor
Peter Esperling
Joachim Kuhnke
Henry Laurent
Thorsten Blume
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20015488D0 publication Critical patent/NO20015488D0/no
Publication of NO20015488L publication Critical patent/NO20015488L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse angår farmasøytisk aktive 14p-H-ster- oler, farmasøytiske blandinger omfatt- ende disse og anvendelse av disse nye forbindelser for fremstilling av medi- kamenter. Det har mer spesielt vist seg at 14p-H-sterolene ifølge oppfinnelsen kan anvendes for å regulere meiose.
NO20015488A 1999-05-10 2001-11-09 14<beta>-H-steroler, farmasöytiske preparater som omfatter dem, og anvendelse av disse derivatene til fremstilling avmeioseregulerende medikamenter NO20015488L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99250153 1999-05-10
PCT/EP2000/004092 WO2000068245A1 (en) 1999-05-10 2000-05-05 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS

Publications (2)

Publication Number Publication Date
NO20015488D0 NO20015488D0 (no) 2001-11-09
NO20015488L true NO20015488L (no) 2002-01-09

Family

ID=8241145

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015488A NO20015488L (no) 1999-05-10 2001-11-09 14<beta>-H-steroler, farmasöytiske preparater som omfatter dem, og anvendelse av disse derivatene til fremstilling avmeioseregulerende medikamenter

Country Status (18)

Country Link
EP (1) EP1177205A1 (no)
JP (1) JP2002544136A (no)
KR (1) KR20020013541A (no)
CN (1) CN1350543A (no)
AU (1) AU4756100A (no)
BG (1) BG106093A (no)
BR (1) BR0010449A (no)
CA (1) CA2373442A1 (no)
CZ (1) CZ20013981A3 (no)
EA (1) EA200101157A1 (no)
EE (1) EE200100592A (no)
HU (1) HUP0201098A2 (no)
IL (1) IL145373A0 (no)
NO (1) NO20015488L (no)
PL (1) PL352029A1 (no)
SK (1) SK16212001A3 (no)
WO (1) WO2000068245A1 (no)
ZA (1) ZA200110073B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
WO2021046678A1 (zh) * 2019-09-09 2021-03-18 邦泰生物工程(深圳)有限公司 一种合成鹅去氧胆酸的方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds

Also Published As

Publication number Publication date
CA2373442A1 (en) 2000-11-16
SK16212001A3 (sk) 2002-02-05
BG106093A (en) 2002-05-31
HUP0201098A2 (en) 2002-08-28
JP2002544136A (ja) 2002-12-24
NO20015488D0 (no) 2001-11-09
BR0010449A (pt) 2002-02-13
PL352029A1 (en) 2003-07-28
CZ20013981A3 (cs) 2002-02-13
EP1177205A1 (en) 2002-02-06
EA200101157A1 (ru) 2002-06-27
KR20020013541A (ko) 2002-02-20
AU4756100A (en) 2000-11-21
EE200100592A (et) 2003-02-17
ZA200110073B (en) 2003-03-06
WO2000068245A1 (en) 2000-11-16
IL145373A0 (en) 2002-06-30
CN1350543A (zh) 2002-05-22

Similar Documents

Publication Publication Date Title
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
NO20011471L (no) Nye orale vedvarende frigivelsesformuleringer
AU6461600A (en) Substituted piperidine compounds useful as modulators of chemokine receptor activity
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
GEP20043161B (en) Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
NO20026064D0 (no) Nye forbindelser
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
CA2385890A1 (en) Controlled release compositions comprising nimesulide
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
NO20023934D0 (no) Nye forbindelser
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
DE602004011966D1 (en) Heterocyclylverbindungen
ATE233754T1 (de) Diphenyl-piperidin derivate
ATE276246T1 (de) Chemische verbindungen
HUP0200055A2 (hu) 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények
NO20052491L (no) Nye vitronektinresepotr antagonistderivater, fremgangsmate til deres fremstilling, anvendelse derav som legemidler og farmasoytiske sammensetninger som inneholder de samme
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
NO20026081L (no) Nye forbindelser
NO20015488L (no) 14&lt;beta&gt;-H-steroler, farmasöytiske preparater som omfatter dem, og anvendelse av disse derivatene til fremstilling avmeioseregulerende medikamenter
DE69813263T2 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
GEP20043377B (en) Pharmaceutical Complex
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application